These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36548043)

  • 1. COVID-19 and practice transformation: Building an office-based opioid treatment program in a family medicine residency practice.
    Colistra AL; Chung YK; Harbove S; Taveras YJ; Letcher A; Biery N; Keister DM
    Fam Syst Health; 2023 Jun; 41(2):235-239. PubMed ID: 36548043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Training in office-based opioid treatment with buprenorphine in US residency programs: A national survey of residency program directors.
    Tesema L; Marshall J; Hathaway R; Pham C; Clarke C; Bergeron G; Yeh J; Soliman M; McCormick D
    Subst Abus; 2018; 39(4):434-440. PubMed ID: 29513136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of a novel office-based opioid treatment program in an internal medicine resident continuity practice.
    Pytell JD; Buresh ME; Graddy R
    Addict Sci Clin Pract; 2019 Dec; 14(1):46. PubMed ID: 31856915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient Barriers and Facilitators to Medications for Opioid Use Disorder in Primary Care.
    Tofighi B; Williams AR; Chemi C; Suhail-Sindhu S; Dickson V; Lee JD
    Subst Use Misuse; 2019; 54(14):2409-2419. PubMed ID: 31429351
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary care and medication management characteristics among patients receiving office-based opioid treatment with buprenorphine.
    Du CX; Shi J; Tetrault JM; Madden LM; Barry DT
    Fam Pract; 2022 Mar; 39(2):234-240. PubMed ID: 34893825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Training in Buprenorphine and Office-Based Opioid Treatment: A Survey of Psychiatry Residency Training Programs.
    Suzuki J; Ellison TV; Connery HS; Surber C; Renner JA
    Acad Psychiatry; 2016 Jun; 40(3):498-502. PubMed ID: 26017618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-year Retention Rates With Office-based Treatment of Buprenorphine for Opioid Use Disorder in a Private Family Medicine Practice.
    Cope K; DeMicco J; Salib J; Michael M; Yakoub P; Daoud K; Cope R
    J Addict Med; 2022 Nov-Dec 01; 16(6):716-721. PubMed ID: 35913992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term retention in Office Based Opioid Treatment with buprenorphine.
    Weinstein ZM; Kim HW; Cheng DM; Quinn E; Hui D; Labelle CT; Drainoni ML; Bachman SS; Samet JH
    J Subst Abuse Treat; 2017 Mar; 74():65-70. PubMed ID: 28132702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Very early disengagement and subsequent re-engagement in primary care Office Based Opioid Treatment (OBOT) with buprenorphine.
    Hui D; Weinstein ZM; Cheng DM; Quinn E; Kim H; Labelle C; Samet JH
    J Subst Abuse Treat; 2017 Aug; 79():12-19. PubMed ID: 28673522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Financial sustainability of payment models for office-based opioid treatment in outpatient clinics.
    Hodgkin D; Horgan C; Bart G
    Addict Sci Clin Pract; 2021 Jul; 16(1):45. PubMed ID: 34225785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Office-Based Opioid Treatment with Buprenorphine (OBOT-B): Statewide Implementation of the Massachusetts Collaborative Care Model in Community Health Centers.
    LaBelle CT; Han SC; Bergeron A; Samet JH
    J Subst Abuse Treat; 2016 Jan; 60():6-13. PubMed ID: 26233698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Financial Model for Team-Based Opioid Use Disorder Treatment.
    Farrar M; White Z; Hulkower S; Fagan EB; Wilson CG
    J Am Board Fam Med; 2020; 33(1):124-128. PubMed ID: 31907253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of hepatitis C treatment initiation and retention in office-based opioid treatment with buprenorphine: a retrospective cohort study.
    Geist ML; Radick AC; Tsui JI; Blalock KL; Adwell A; Tamru E; Connolly NC; James JR
    Addict Sci Clin Pract; 2023 May; 18(1):33. PubMed ID: 37231486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Value of Treating Opioid Use Disorder in Family Medicine: From the Patient Perspective.
    Kane C; Leiner C; Harless C; Foley KA; Fagan EB; Wilson CG
    J Am Board Fam Med; 2020; 33(4):611-615. PubMed ID: 32675272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychoactive medications and disengagement from office based opioid treatment (obot) with buprenorphine.
    Weinstein ZM; Cheng DM; Quinn E; Hui D; Kim H; Gryczynski G; Samet JH
    Drug Alcohol Depend; 2017 Jan; 170():9-16. PubMed ID: 27865152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Innovative Model for Implementing Office-Based Opioid Treatment in Community-Based Settings.
    Brooks EM; Brasler P
    J Health Care Poor Underserved; 2020; 31(3):1054-1060. PubMed ID: 33416680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staff Attitudes toward Buprenorphine before and after Implementation of an Office-Based Opioid Treatment Program in an Urban Teaching Clinic.
    James JR; Marolf M; Klein JW; Blalock KL; Merrill JO; Tsui JI
    Subst Use Misuse; 2021; 56(11):1569-1575. PubMed ID: 34282999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safer in care: A pandemic-tested model of integrated HIV/OUD care.
    Eaton EF; Tamhane A; Turner W; Raper JL; Saag MS; Cropsey KL
    Drug Alcohol Depend; 2022 Feb; 231():109241. PubMed ID: 35007957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing and Evaluating COVID-19 Protocols for an Office-Based Opioid Treatment Program in an Urban Underserved Setting.
    O'Gurek DT
    J Am Board Fam Med; 2021 Feb; 34(Suppl):S136-S140. PubMed ID: 33622828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19: A catalyst for change in telehealth service delivery for opioid use disorder management.
    Mehtani NJ; Ristau JT; Snyder H; Surlyn C; Eveland J; Smith-Bernardin S; Knight KR
    Subst Abus; 2021; 42(2):205-212. PubMed ID: 33684331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.